The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis

Modern Pathology

Volumn 25, Issue 3, 2012, Pages 416-433

  Nuovo, Gerard J ^a   Hagood, James S ^b   Magro, Cynthia M ^c   Chin, Nena ^d   Kapil, Rubina ^a   Davis, Luke ^a   Marsh, Clay B ^a   Folcik, Virginia A ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

^c Department of Obstetrics Gynecology   (United States)

^d Accurate Diagnostic Labs   (United States)

Author keywords

co expression analysis; idiopathic pulmonary fibrosis; IL 17; immunohistochemistry; inflammation; retinoic acid related orphan receptors; usual interstitial pneumonia

Indexed keywords

B7 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR6; CHLORDANE; CYTOKERATIN; INTERLEUKIN 17; PROTEIN S 100; RETINOID RELATED ORPHAN RECEPTOR ALPHA; RETINOID RELATED ORPHAN RECEPTOR BETA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL REGENERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EPITHELIUM CELL; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; LUNG ALVEOLUS CELL; LUNG BIOPSY; LUNG INTERSTITIUM; LUNG PARENCHYMA; MACROPHAGE; MALE; MONONUCLEAR CELL; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

EID: 84857788968     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.166     Document Type: Article

References (98)

1. Olsen AL, Swigris JJ, Lezotte DC, et al. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med 2007;176:277-284.
2. Raghu G, Collard HR, Egan JJ, et al. American Thoracic Society Documents. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
3. Katzenstein A-LA, Mukhopadhyay S, Myers JL. Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases. Hum Pathol 2008;39:1562-1581.
4. Chapman HA. Disorders of lung matrix remodeling. J Clin Invest 2004;113:148-157.
5. Selman M, Pardo A, Kaminski N. Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs? PLoS Med 2008;5:e62.
6. Bringardner BD, Baran CP, Eubank TD, et al. The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. Antioxid Redox Signal 2008;10: 287-301.
7. Magro CM, Allen J, Pope-Harman A, et al. The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis. Anat Pathol 2003;119: 556-567.
8. Magro CM, Waldman WJ, Knight DA, et al. Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies. Hum Immunol 2006; 67:284-297.
9. Tang Y-W, Johnson JE, Browning PJ, et al. Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol 2003;41:2633-2640.
10. Bhatt N, Baran CP, Allen J, et al. Promising pharmacologic innovations in treating pulmonary fibrosis. Curr Opin Pharmacol 2006;6:284-292.
11. Wilson MS, Madala SK, Ramalingam TR, et al. Bleomycin and IL-1B-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 2010;207:1-18.
12. Kotton DN, Ma BY, Cardoso WV, et al. Bone marrowderived cells as progenitors of lung alveolar epithelium. 2001;128:5181-5188.
13. Hashimoto N, Jin H, Liu T, et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004;113:243-252.
14. Mehrad B, Burdick MD, Strieter RM. Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis. Int J Biochem Cell Biol 2009;41:1708-1718.
15. Moeller A, Gilpin SE, Ask K, et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009;179:588-594.
16. Garcia-de-Alba C, Becerril C, Ruiz V, et al. Expression of matrix metalloproteases by fibrocytes: possible role in migration and homing. Am J Respir Crit Care Med 2010;182:1144-1152.
17. Andersson-Sjoland A, Garcia-de-Alba C, Nihlberg K, et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 2008;40:2129-2140.
18. Cool CD, Groshong SD, Rai PR, et al. Fibroblastic foci are not discrete sites of lung injury or repair. Am J Respir Crit Care Med 2006;174:654-658.
19. Yamada M, Kuwano K, Maeyama T, et al. Dualimmunohistochemistry provides little evidence for epithelial-mesenchymal transition in pulmonary fibrosis. Histochem Cell Biol 2008;129:453-462.
20. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112:1776-1784.
21. Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005;6:1123-1132.
22. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005;6:1133-1141.
23. Weaver CT, Hatton RD, Mangan PR, et al. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007;25:821-852.
24. Feuerer M, Hill JA, Mathis D, et al. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol 2009;10:689-695.
25. Nuovo GJ. In situ detection of microRNAs in paraffin embedded, formalin fixed tissues and the co-localization of their putative targets. Methods 2010;52: 307-315.
26. Nuovo GJ, Elton TS, Nana-Sinkam P, et al. A methodology for the combined in situ analyses of the precursor and mature forms of microRNAs and correlation with their putative targets. Nat Protoc 2009;4:107-115.
27. Mansfield JR. Cellular context in epigenetics: quantitative multicolor imaging and automated percell analysis of miRNAs and their putative targets. Methods 2010;52:271-280.
28. Marchal-Somme J, Uzunhan Y, Marchand-Adam S, et al. Cutting Edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. J Immunol 2006;176:5735-5739.
29. Craig W, Kay R, Cutler RL, et al. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 1993;177:1331-1342.
30. Ehrchen JM, Sunderkotter C, Foell D, et al. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 2009;86: 557-566.
31. Lim SY, Raftery MJ, Goyette J, et al. Oxidative modifications of S100 proteins: functional regulation by redox. J Leukoc Biol 2009;86:577-587.
32. Liao F, Rabin RL, Smith CS, et al. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3a. J Immunol 1999;162: 186-194.
33. Pene J, Chavalier S, Preisser L, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008;180: 7423-7430.
34. Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat, directs the differentiation program of proinflammatory IL-17 T helper cells. Cell 2006;126:1121-1133.
35. Manel N, Unutmaz D, Littman DR. The differentiation of human Th-17 cells requires transforming growth factor-B and induction of the nuclear receptor RORyt. Nat Immunol 2008;9:641-649.
36. Kurebayashi S, Ueda E, Sakaue M, et al. Retinoidrelated orphan receptor gamma (RORgamma) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis. Proc Natl Acad Sci 2000;97: 10132-10137.
37. Dzhagalov I, Giguere V, He Y-W. Lymphocyte development and function in the absence of retinoic acid-related orphan receptor a. J Immunol 2004;173: 2952-2959.
38. Yang XO, Pappu BP, Nurieva R, et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors RORalpha and ROR gamma. Immunity 2008;28:29-39.
39. Song C, Luo L, Lei Z, et al. IL-17-producing alveolar macrophages mediate allergic lung imflammation related to asthma. J Immunol 2008;181: 6117-6124.
40. Zhu X, Mulcahy LA, Mohammed RAA, et al. IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Res 2008;10:R95.
41. Coury F, Annels N, Rivollier A, et al. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat Med 2008;14: 81-87.
42. Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001;108:430-438.
43. Doe C, Bafadhel M, Siddiqui S, et al. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in Asthma and COPD. Chest 2010;138:1140-1147.
44. Joshi AD, Fong DJ, Oak SR, et al. Interleukin-17-mediated immunopathogenesis in experimental hypersensitivity pneumonitis. Am J Respir Crit Care Med 2009;179:705-716.
45. Bettelli E, Oukka M, Kuchroo VK. Th-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007;8:345-350.
46. Kleinewietfeld M, Puentes F, Borsellino G, et al. CCR6 expression defines regulatory effector/memory-like cells within the CD25+CD4+ T-cell subset. Blood 2005;105:2877-2886.
47. Yamazaki T, Yang XO, Chung Y, et al. CCR6 regulates the migration of inflammatory and regulatory T cells. J Immunol 2008;181:8391-8401.
48. Kotsianidis I, Nakou E, Bouchliou I, et al. Global impairment of CD4+ CD25+ FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009;179:1121-1130.
49. Yang CC, Ogawa H, Dwinell MB, et al. Chemokine receptor CCR6 transduces signals that activate p130Cas and alter cAMP-stimulated ion transport in human intestinal epithelial cells. Am J Physiol Cell Physiol 2005;288:C321-C3C8.
50. Vongsa RA, Zimmerman NP, Dwinell MB. CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2-and CCL20-mediated restitution of colonic epithelial cells. J Biol Chem 2009;284: 10034-10045.
51. Steinmayr M, Andre E, Conquet F, et al. Staggerer phenotype in retinoid-related orphan receptor a-deficient mice. Proc Natl Acad Sci 1998;95:3960-3965.
52. Andre E, Conquet F, Steinmayr M, et al. Disruption of retinoid-related orphan receptor b changes circadian behavior, causes retinal degeneration and leads to vacillans phenotype in mice. EMBO J 1998;17: 3867-3877.
53. Stehlin-Gaon C, Willmann D, Zeyer D, Sanglier S, Dorsselaer AV, Renaud J-P, et al. All-trans retinoic acid is a ligand for the orphan nuclear receptor RORb. Nat Struct Biol 2003;10:820-825.
54. Massaro GD, Massaro D. Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats. Am J Physiol 1996;270:L305-LL10.
55. Degos L, Wang ZY. All trans retinoic acid in acute promyelocytic leukemia. Oncogene 2001;20: 7140-7145.
56. Zhu Y, McAvoy S, Kuhn R, et al. RORA, a large common fragile site gene, is involved in cellular stress response. Oncogene 2006;25:2901-2908.
57. Miki N, Ikuta M, Matsui T. Hypoxia-induced activation of the retinoic acid receptor-related orphan receptor a4 gene by an interaction between hypoxiainducible factor-1 and sp1. J Biol Chem 2004;279: 15025-15031.
58. Moseley TA, Haudenschild DR, Rose L, et al. Interleukin-family and IL-17 receptors. Cytokine Growth Factor Rev 2003;14:155-174.
59. Sanders YY, Pardo A, Selman M, et al. Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. Am J Respir Cell Mol Biol 2008;39:610-618.
60. Beilhack A, Rockson SG. Immune traffic: a functional overview. Lymphat Res Biol 2003;1:219-234.
61. Lotze MT, Tracey KJ. High-mobility group box 1 (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005;5:331-342.
62. El-Zammar O, Rosenbaum P, Katzenstein A-LA. Proliferative activity in fibrosing lung diseases: a comparative study of Ki-67 immunoreactivity in diffuse alveolar damage, bronchiolitis obliterans-organizing pneumonia, and usual interstitial pneumonia. Hum Pathol 2009;40:1182-1188.
63. Piguet PF, Ribaux C, Karpuz V, et al. Expression and localization of tumor necrosis factor-a and its mRNA in idiopathic pulmonary fibrosis. Am J Pathol 1993;143:651-655.
64. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003;60:540-551.
65. Nacken W, Roth J, Sorg C, et al. S100A9/S100A8: myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech 2003;60:569-580.
66. Pilling D, Fan T, Huang D, et al. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PloS One 2009;4:e7475.
67. Liang SC, Tan X-Y, Luxenberg DP, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006;203:2271-2279.
68. Feghali-Bostwick CA, Tsai CG, Valentine VG, et al. Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis. J Immunol 2007;179:2592-2599.
69. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper Tcells. N Engl J Med 2009;361:888-898.
70. Nascimento CR, Freire-de-Lima CG, Oliveira AdSd, et al. The short chain fatty acid sodium butyrate regulates the induction of CD1a in developing dendritic cells. Immunobiology 2011;216:275-284.
71. Reinherz EL, Kung PC, Goldstein G, et al. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of Tcell lineage. Proc Natl Acad Sci 1980;77:1588-1592.
72. Zajonc DM, Kronenberg M. CD1 mediated T cell recognition of glycolipids. Curr Opin Struct Biol 2007; 17:521-529.
73. Rocca GL, Anzalone R, Bucchieri F, et al. CD1a and antitumour immune response. Immunol Lett 2004;95: 1-4.
74. Groh V, Gadner H, Radaszkiewicz T, et al. The phenotypic spectrum of histiocytosis X cells. J Invest Dermatol 1988;90:441-447.
75. Haskins K, Kubo R, White J, et al. The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. J Exp Med 1983;157:1149-1169.
76. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations. Annu Rev Immunol 2010; 28:445-489.
77. Shiku H, Kisielow P, Bean MA, et al. Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. J Exp Med 1975; 141:227-241.
78. Norment AM, Salter RD, Parham P, et al. Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 1988;336:79-81.
79. Anolik J, Looney RJ, Bottaro A, et al. Down-regulation of CD20 on B cells upon CD40 activation. Eur J Immunol 2003;33:2398-2409.
80. Kuwana M, Okazaki Y, Kodama H, et al. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol 2003;74:833-845.
81. Wood HB, May G, Healy L, et al. CD34 expression patterns during early mouse development are related to modes of blood vessel formation and reveal additional sites of hematopoiesis. Blood 1997;90: 2300-2311.
82. Curnow SJ, Fairclough M, Schmutz C, et al. Distinct types of fibrocyte can differentiate from mononuclear cells in the presence and absence of serum. PLoS One 2010;5:e9730.
83. Romagnani P, Annunziato F, Liotta F, et al. CD14+ CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 2005;97:314-322.
84. Kuwana M, Okazaki Y, Kodama H, et al. Endothelial differentiation potential of human monocyte-derived multipotential cells. Stem Cells 2006;24:2733-2743.
85. Trowbridge IS. CD45: An emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol 1994;12: 85-116.
86. Robertson MJ, Ritz J. Biology and Clinical relevance of human natural killer cells. Blood 1990;76:2421-2438.
87. Kunisch E, Fuhrmann R, Roth A, et al. Macrophage specificity of three anti-CD-68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann Rheum Dis 2004;63:774-784.
88. Fujii S-I, Liu K, Smith C, et al. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 2004;199: 1607-1618.
89. Linsley PS, Clark EA, Ledbetter JA. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci 1990;87:5031-5035.
90. Tsunawaki S, Nakamura S, Ohyama Y, et al. Possible function of salivary gland epithelial cells as nonprofessional antigen-presenting cells in the development of Sjogren's syndrome. J Rheumatol 2002;29:1884-1896.
91. Listrom MB, Dalton LW. Comparison of keratin monoclonal antibodies MAK-6, AE1:AE3, and CAM-5.2. Am J Clin Pathol 1987;88:297-301.
92. Moll R, Franke WW, Schiller DL, et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31:11-24.
93. Tamas EF, Epstein JI. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains. Am J Surg Pathol 2007;31:390-397.
94. Jetten AM. Recent advances in the mechanisms of action and physiological functions of the Retinoid-Related Orphan Receptors (RORs). Curr Drug Targets Inflamm Allergy 2004;3:395-412.
95. Jetten AM, Ueda E. Retinoid-related orphan receptors (RORs): roles in cell survival, differentiation and disease. Cell Death Differ 2002;9:1167-1171.
96. Sawa S, Cherrier M, Lochner M, et al. Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science 2010;330:665-669.
97. Raichur S, Lau P, Staels B, et al. Retinoid-related orphan receptor gamma regulates several genes that control metabolism in skeletal muscle cells: links to modulation of reactive oxygen species production. J Mol Endocrinol 2007;39:29-44.
98. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001;104:487-501.